School of Medicine, University of California San Diego, San Diego, California, United States of America.
PLoS One. 2009 Dec 30;4(12):e8504. doi: 10.1371/journal.pone.0008504.
The Centers for Disease Control recommend screening for asymptomatic sexually transmitted infection (STI) among HIV-infected men when there is self-report of unprotected anal-receptive exposure. The study goals were: (1) to estimate the validity and usefulness for screening policies of self-reported unprotected anal-receptive exposure as a risk indicator for asymptomatic anorectal infection with Neisseria gonorrhoeae (GC) and/or Chlamydia trachomatis (CT). (2) to estimate the number of infections that would be missed if anal diagnostic assays were not performed among patients who denied unprotected anorectal exposure in the preceding month.
Retrospective analysis in HIV primary care and high resolution anoscopy (HRA) clinics. HIV-infected adult men were screened for self-reported exposure during the previous month at all primary care and HRA appointments. Four sub-cohorts were defined based on microbiology methodology (GC culture and CT direct fluorescent antibody vs. GC/CT nucleic acid amplification test) and clinical setting (primary care vs. HRA). Screening question operating characteristics were estimated using contingency table methods and then pooled across subcohorts. Among 803 patients, the prevalence of anorectal GC/CT varied from 3.5-20.1% in the 4 sub-cohorts. The sensitivity of the screening question for self-reported exposure to predict anorectal STI was higher in the primary care than in the HRA clinic, 86-100% vs. 12-35%, respectively. The negative predictive value of the screening question to predict asymptomatic anorectal STI was > or = 90% in all sub-cohorts. In sensitivity analyses, the probability of being an unidentified case among those denying exposure increased from 0.4-8.1% in the primary care setting, and from 0.9-18.8% in the HRA setting as the prevalence varied from 1-20%.
As STI prevalence increases, denial of unprotected anal-receptive exposure leads to an increasingly unacceptable proportion of unidentified asymptomatic anorectal STI if used as a criterion not to obtain microbiologic assays.
美国疾病控制与预防中心建议,当 HIV 感染者自述有过无保护的肛交行为时,对其进行无症状性性传播感染(STI)筛查。本研究的目的是:(1)评估自述无保护肛交行为作为无症状肛门直肠淋病奈瑟菌(GC)和/或沙眼衣原体(CT)感染的风险指标,用于筛查政策的有效性和实用性。(2)如果在过去一个月中否认有过无保护的肛门直肠接触的患者不进行肛门诊断检测,估计会遗漏多少感染。
在 HIV 初级保健和高分辨率肛门镜(HRA)诊所进行回顾性分析。在所有初级保健和 HRA 就诊时,对 HIV 感染的成年男性进行关于上个月报告的暴露情况的筛查。根据微生物学方法(GC 培养和 CT 直接荧光抗体与 GC/CT 核酸扩增试验)和临床环境(初级保健与 HRA),将 HIV 感染者分为 4 个亚组。使用列联表方法估计筛查问题的操作特征,然后将其汇总到各亚组中。在 803 名患者中,4 个亚组的肛门直肠 GC/CT 患病率从 3.5%到 20.1%不等。在初级保健诊所,自述暴露于肛交来预测肛门直肠 STI 的筛查问题的敏感性高于 HRA 诊所,分别为 86-100%和 12-35%。在所有亚组中,筛查问题对预测无症状肛门直肠 STI 的阴性预测值均大于等于 90%。在敏感性分析中,在初级保健环境中,当 STI 流行率从 1%到 20%变化时,否认无保护肛交的情况下,未被识别的病例的概率从 0.4%到 8.1%增加;在 HRA 环境中,否认无保护肛交的情况下,未被识别的病例的概率从 0.9%到 18.8%增加。
随着 STI 流行率的增加,如果将否认无保护的肛交行为作为不进行微生物检测的标准,那么这将导致越来越多的无症状肛门直肠 STI 无法被识别。